Subcutaneous tumour graft and orthotopic tumour experiments in mice showed that downregulation of ITGB4 significantly enhanced the therapeutic effect of PD‐1 antibodies on pancreatic cancer.66 The gene discussed is ITGB4; the disease is familial pancreatic carcinoma.